Cardax Pharmaceuticals becomes Hawaii’s 16th publicly-traded company

Cardax Pharmaceuticals, a Hawaii-based life sciences company that is developing safe, anti-inflammatory drugs to combat chronic illnesses such as rheumatoid arthritis, cardiovascular disease and diabetes, said Friday that it is officially a public company after completing a reverse merger with a publicly-traded Houston coffee-roasting firm...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.